Results 201 to 210 of about 30,050 (254)

Progress of Immunotherapies in Parkinson's Disease

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 6, June 2026.
Parkinson's disease (PD) is caused by an immune disorder triggered by α‐synuclein, leading to a persistent neuroinflammatory cycle that drives the disease from non‐motor symptoms to the motor stage. Second, it presents active and passive immunotherapy strategies targeting α‐synuclein and their potential in slowing down the disease progression.
Yong Peng   +10 more
wiley   +1 more source

Impact of fecal microbiota transplantation in dogs. [PDF]

open access: yesFront Vet Sci
Cantas L   +4 more
europepmc   +1 more source

Fecal microbiota transplantation in allergic diseases. [PDF]

open access: yesWorld J Methodol
Tüsüz Önata E, Özdemir Ö.
europepmc   +1 more source

Feasibility of antibiotic-assisted fecal microbiota transplantation with immunotherapy for esophageal and gastric cancer. [PDF]

open access: yesFuture Oncol
Yoshinami Y   +16 more
europepmc   +1 more source

Fecal microbiota transplantation from psychiatric patients to mice - systematic review of methodologies and a call for standardization. [PDF]

open access: yesTransl Psychiatry
D'Onofrio AM   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy